https://orcid.org/0000-0003-1197-2641
References
- Zamani M, Grønhøj C, Jensen DH, et al. The current epidemic of HPV-associated oropharyngeal cancer: an 18-year Danish population-based study with 2,169 patients. Eur J Cancer. 2020;134:52–59.
- Garnaes E, Kiss K, Andersen L, et al. A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: The largest registry-based study to date. Int J Cancer. 2015;136(9):2196–2203.
- Garnaes E, Kiss K, Andersen L, et al. Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients. Br J Cancer. 2015;113(1):131–134.
- Carlander ALF, Grønhøj Larsen C, Jensen DH, et al. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: a Danish population-based study from 2011 to 2014. Eur J Cancer. 2017;70:75–82.
- Larsen CG, Jensen DH, Fenger Carlander A-L, et al. Novel nomograms for survival and progression in HPV + and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients. Oncotarget. 2016;7(44):71761–71772.
- Garnaes E, Frederiksen K, Kiss K, et al. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study. Int J Cancer. 2016;139(11):2598–2605.
- Marklund L, Hammarstedt L. Impact of HPV in oropharyngeal cancer. J Oncol. 2011;2011:509036.
- Sansoni ER, Gross ND. The role of transoral robotic surgery in the management of oropharyngeal squamous cell carcinoma: a current review. Curr Oncol Rep. 2015;17(3):432.
- Dowthwaite S. a, Franklin JH, Palma D. a, et al. The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature. ISRN Oncol. 2012;2012:945162.
- Ling DC, Chapman BV, Kim J, et al. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation. Oral Oncol. 2016;61:41–46.
- Wasywich CA, Gamble GD, Whalley GA, et al. Understanding changing patterns of survival and hospitalization for heart failure over two decades in New Zealand: Utility of “'days alive and out of hospital' from epidemiological data”. Eur J Heart Fail. 2010;12(5):462–468.
- Ariti CA, Cleland JGF, Pocock SJ, et al. Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J. 2011;162(5):900–906.
- Jørgensen CC, Petersen PB, Kehlet H, et al. Days alive and out of hospital after fast-track total hip and knee arthroplasty: an observational cohort study in 16 137 patients. Br J Anaesth. 2019;123(5):671–678.
- Jerath A, Austin PC, Wijeysundera DN. Days alive and out of hospital: validation of a patient-centered outcome for perioperative medicine . Anesthesiology. 2019;131(1):84–93.
- Bell M, Eriksson LI, Svensson T, et al. Days at home after surgery: an integrated and efficient outcome measure for clinical trials and quality assurance. EClinicalMedicine. 2019;11(xxxx):18–26.
- Myles PS, Shulman MA, Heritier S, et al. Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia. BMJ Open. 2017;7(8):e015828.
- Rubek N, Channir HI, Charabi BW, et al. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status. Eur Arch Otorhinolaryngol. 2017;274(5):2229–2237.